Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice
Authors
Keywords
Hepatocytes, Necrosis, Pancreas, Enzyme-linked immunoassays, Liver, Bone marrow cells, Epithelial cells, In vivo imaging
Journal
PLoS Pathogens
Volume 14, Issue 8, Pages e1007235
Publisher
Public Library of Science (PLoS)
Online
2018-08-04
DOI
10.1371/journal.ppat.1007235
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effusive-constrictive pericarditis, hepatitis, and pancreatitis in a patient with possible coxsackievirus B infection: a case report
- (2016) Jon Persichino et al. BMC INFECTIOUS DISEASES
- Superoxide Dismutase 1 Protects Hepatocytes from Type I Interferon-Driven Oxidative Damage
- (2015) Anannya Bhattacharya et al. IMMUNITY
- Type I interferons mediate pancreatic toxicities of PERK inhibition
- (2015) Qiujing Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis
- (2015) Jon Sin et al. VIROLOGY
- Efficient Virus Assembly, but Not Infectivity, Determines the Magnitude of Hepatitis C Virus-Induced Interferon Alpha Responses of Plasmacytoid Dendritic Cells
- (2015) Elena Grabski et al. JOURNAL OF VIROLOGY
- Type III interferons are expressed by Coxsackievirus-infected human primary hepatocytes and regulate hepatocyte permissiveness to infection
- (2014) K. Lind et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Type I IFN-Mediated Protection of Macrophages and Dendritic Cells Secures Control of Murine Coronavirus Infection
- (2014) L. Cervantes-Barragan et al. JOURNAL OF IMMUNOLOGY
- Independent of Plasmacytoid Dendritic Cell (pDC) infection, pDC Triggered by Virus-Infected Cells Mount Enhanced Type I IFN Responses of Different Composition as Opposed to pDC Stimulated with Free Virus
- (2014) Theresa Frenz et al. JOURNAL OF IMMUNOLOGY
- Type I Interferon Signals in Macrophages and Dendritic Cells Control Dengue Virus Infection: Implications for a New Mouse Model To Test Dengue Vaccines
- (2014) R. Zust et al. JOURNAL OF VIROLOGY
- In Vivo Ablation of Type I Interferon Receptor from Cardiomyocytes Delays Coxsackieviral Clearance and Accelerates Myocardial Disease
- (2014) N. Althof et al. JOURNAL OF VIROLOGY
- Human but Not Mouse Hepatocytes Respond to Interferon-Lambda In Vivo
- (2014) Pascale Hermant et al. PLoS One
- Explanted Diseased Livers – A Possible Source of Metabolic Competent Primary Human Hepatocytes
- (2014) Moritz Kleine et al. PLoS One
- Protection against RNA-induced liver damage by myeloid cells requires type I interferon and IL-1 receptor antagonist in mice
- (2013) Elea Conrad et al. HEPATOLOGY
- Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression
- (2013) Christopher R. Bolen et al. HEPATOLOGY
- Immune surveillance by the liver
- (2013) Craig N Jenne et al. NATURE IMMUNOLOGY
- Hepatic damage caused by coxsackievirus B3 is dependent on age-related tissue tropisms associated with the coxsackievirus-adenovirus receptor
- (2013) Jung-Yen Liu et al. Pathogens and Disease
- Innate Immune Tolerance and the Role of Kupffer Cells in Differential Responses to Interferon Therapy Among Patients With HCV Genotype 1 Infection
- (2012) Daryl T.–Y. Lau et al. GASTROENTEROLOGY
- MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration
- (2012) Qinggong Yuan et al. HEPATOLOGY
- Mycobacterial Disease and Impaired IFN- Immunity in Humans with Inherited ISG15 Deficiency
- (2012) D. Bogunovic et al. SCIENCE
- Epidermal growth factor improves lentivirus vector gene transfer into primary mouse hepatocytes
- (2011) M Rothe et al. GENE THERAPY
- Production of IFN-β during Listeria monocytogenes Infection Is Restricted to Monocyte/Macrophage Lineage
- (2011) Evgenia Solodova et al. PLoS One
- Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice
- (2010) Philipp A. Lang et al. HEPATOLOGY
- Temporal and Spatial Resolution of Type I and III Interferon Responses In Vivo
- (2010) J. E. Pulverer et al. JOURNAL OF VIROLOGY
- Ontogeny of Toll-Like Receptor Mediated Cytokine Responses of Human Blood Mononuclear Cells
- (2010) Nathan P. Corbett et al. PLoS One
- Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection
- (2010) K. Takahashi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Melanoma differentiation-associated protein-5 (MDA-5) limits early viral replication but is not essential for the induction of type 1 interferons after Coxsackievirus infection
- (2010) Michael H. Hühn et al. VIROLOGY
- Virus-Induced Unfolded Protein Response Attenuates Antiviral Defenses via Phosphorylation-Dependent Degradation of the Type I Interferon Receptor
- (2009) Jianghuai Liu et al. Cell Host & Microbe
- Novel Reporter Mouse Reveals Constitutive and Inflammatory Expression of IFN- In Vivo
- (2009) S. Lienenklaus et al. JOURNAL OF IMMUNOLOGY
- MDA5 and MAVS Mediate Type I Interferon Responses to Coxsackie B Virus
- (2009) J. P. Wang et al. JOURNAL OF VIROLOGY
- Interferon-λ Contributes to Innate Immunity of Mice against Influenza A Virus but Not against Hepatotropic Viruses
- (2008) Markus Mordstein et al. PLoS Pathogens
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More